Inhibition of platelet-rich arterial thrombus in vivo: Acute antithrombotic effect of intravenous HMG-CoA reductase therapy

Keyphrases

• Lovastatin 100%
• Antithrombotic Effect 100%
• Platelet-rich 100%
• HMG-CoA Reductase 100%
• Arterial Thrombus 100%
• Thrombotic 33%
• Carotid Artery 33%
• Carotid Injury 33%
• Simvastatin 16%
• Porcine 16%
• Statins 16%
• Platelets 16%
• Whole Blood 16%
• Incubation 16%
• Bolus 16%
• Arterial Injury 16%
• Thrombus 16%
• Injury Model 16%
• Class Effect 16%
• Saline Control 16%
• Arterial Thrombosis 16%
• Thrombus Formation 16%
• Platelet Function 16%
• Scintillation Detection 16%
• Flow Chamber 16%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 16%
• Dense Granule Secretion 16%
• Platelet Deposition 16%
• Platelet Thrombus 16%
• Closure Time 16%
• Platelet Dense Granules 16%
• Thrombus Volume 16%

Medicine and Dentistry

• Platelet 100%
• Antithrombotic 100%
• Artery Thrombosis 100%
• Hydroxymethylglutaryl Coenzyme A Reductase 100%
• Lovastatin 100%
• Injury 50%
• Thrombus 33%
• Carotid Artery 33%
• In Vitro 16%
• Statin 16%
• Secretion (Process) 16%
• Infusion 16%
• Incubation 16%
• Artery Injury 16%
• Oxidoreductase 16%
• Simvastatin 16%
• Blood Clotting 16%
• Scintiscanning 16%
• Dense Granule 16%
• Thrombocyte Function 16%
• Artery 16%
• Glutaryl-CoA 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Anticoagulant Agent 100%
• Mevinolin 100%
• Hydroxymethylglutaryl Coenzyme A Reductase 100%
• Artery Thrombosis 100%
• Thrombus 50%
• Injury 50%
• Pig 16%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 16%
• Oxidoreductase 16%
• Artery Injury 16%
• Glutaryl-CoA 16%
• Simvastatin 16%